Selank Peptide: Complete Research Overview (2026)

Interest in synthetic neuropeptide research in Canada has expanded considerably within laboratory and preclinical research communities. Selank (also designated TP-7, CAS 129954-34-3) is a synthetic heptapeptide analogue of human tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is studied in experimental settings for its interactions with neurotransmitter systems, enkephalin metabolism, and immune signalling pathways.

Written by the NexPept Research Team · Last updated: July 2026

This page provides a complete educational overview of Selank peptide for laboratory research purposes only. NexPept supplies Selank strictly for non-clinical, in vitro research applications, with an emphasis on purity, documentation, and batch consistency.

What Is Selank?

Selank is a synthetic heptapeptide developed as a metabolically stabilized analogue of tuftsin — a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) derived from the Fc region of immunoglobulin G. To extend the compound's in vitro half-life and metabolic stability, researchers appended a Pro-Gly-Pro tripeptide to the C-terminus of the tuftsin sequence, yielding the 7-amino-acid chain Thr-Lys-Pro-Arg-Pro-Gly-Pro.

Selank is synthesized for in vitro laboratory research use and is examined for its modulatory effects on neurotransmitter systems — particularly GABAergic signalling, serotonin metabolism, and enkephalin degradation pathways. Its structural derivation from an endogenous immunomodulatory peptide and its multi-target research profile have made it a subject of sustained preclinical interest, particularly in neuropharmacology research.

Selank Molecular Profile

Why Researchers Study Selank

In laboratory and preclinical research environments, Selank peptide has been investigated for its modulatory interactions across multiple neurochemical systems. Unlike single-target research peptides, Selank's preclinical literature spans GABAergic modulation, monoamine metabolism, and endogenous opioid peptide preservation — making it a compound of broad interest in neuropharmacology and neurochemistry research.

Research applications documented in the preclinical literature include:

• GABA-A receptor modulation and anxiolytic-like activity in in vitro and animal models
• Serotonin metabolism and monoamine neurotransmitter concentration studies
• Enkephalinase inhibition — inhibition of enzymes that degrade endogenous enkephalin peptides
• Immune signalling research, including IL-6 modulation and T-helper cytokine balance studies
• Nootropic and cognitive function research in preclinical models
• Metabolic stability studies of tuftsin-derived peptide analogues
• Comparative structure–activity research between Selank and the parent tuftsin sequence

Selank and the Tuftsin Connection

Understanding Selank's structural origin is important for interpreting its research profile. Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) cleaved from the Fc fragment of immunoglobulin G. It was first characterized for its immunostimulatory properties and has been extensively studied for its interactions with immune cells and the central nervous system.

The challenge with tuftsin as a research compound is its rapid enzymatic degradation in biological systems — it is quickly cleaved by tuftsinase and other proteases. Selank was developed to address this limitation: the Pro-Gly-Pro tripeptide appended to the C-terminus of the tuftsin sequence confers enhanced metabolic stability, substantially extending the compound's half-life in experimental systems relative to the parent peptide.

This structural modification, combined with Selank's retention of the core tuftsin sequence, has made it a useful research tool for investigating tuftsin-related biology in in vitro models where the rapid degradation of native tuftsin would otherwise confound experimental design. Researchers studying the neurochemical and immunological roles of endogenous tuftsin-like peptides often use Selank as a stabilized experimental surrogate.

Selank Neurochemical Research Pathways

Selank's preclinical literature identifies several distinct neurochemical mechanisms studied in experimental settings. These pathways are summarized below for laboratory research context.

GABAergic Modulation

Selank has been studied for its interactions with the GABA-A receptor system in vitro and in animal models. Research has examined its anxiolytic-like profile in comparison to classical benzodiazepine compounds, with investigators noting a distinct mechanism distinct from direct GABA-A agonism. The precise allosteric site and binding dynamics remain an active area of in vitro investigation.

Enkephalinase Inhibition

One of Selank's most studied mechanisms is its inhibition of enkephalin-degrading enzymes. Enkephalins are endogenous opioid pentapeptides that modulate pain, mood, and immune signalling. By inhibiting the enzymatic degradation of enkephalins, Selank is studied as a tool for preserving endogenous opioid peptide availability in experimental systems — a property relevant to research examining endogenous opioid signalling pathways.

Serotonin and Monoamine Metabolism

Preclinical studies have examined Selank's influence on serotonin (5-HT) concentration and monoamine neurotransmitter metabolism in animal models. Research in this area has investigated the peptide's effects on tryptophan hydroxylase activity and serotonergic tone, contributing to its profile as a multi-target neurochemical research tool.

Immune Signalling Research

Consistent with its tuftsin origin, Selank has been examined for immunomodulatory properties in preclinical models, including modulation of IL-6 expression and effects on the balance of T-helper cell cytokine profiles. This dual neuro-immune research profile is relatively uncommon among synthetic research peptides and has contributed to sustained interest in Selank within experimental neuroscience.

Selank and Semax: Frequently Studied Together

In research settings, Selank is frequently studied alongside Semax — another synthetic neuropeptide of Russian origin, derived from ACTH(4–7). While the two compounds have distinct mechanisms of action and molecular targets, their complementary preclinical research profiles — Semax being studied primarily for neurotrophic factor modulation (BDNF, NGF) and Selank for GABAergic and enkephalinase pathways — have led investigators to examine them in combination in preclinical animal models.

NexPept supplies both Selank and Semax individually as well as the Semax + Selank Blend for researchers who require both compounds in a single formulation. Each compound is independently verified to ≥99% purity with batch-specific COA documentation.

Purity & Documentation for Selank Research

High peptide purity is critical for reproducible in vitro research outcomes, particularly for neurochemically active heptapeptides like Selank, where impurities at sub-percent levels can introduce confounding variables in receptor binding and enzymatic assay work.

When evaluating a Selank peptide supplier in Canada, researchers should look for:

• Third-party analytical testing — HPLC and mass spectrometry performed by an independent laboratory
• Batch-specific identification — each vial traceable to a documented production lot with its own COA
• Verified purity percentages — ≥99% purity is the accepted benchmark for research-grade peptides
• Certificates of Analysis (COAs) from independent laboratories, not in-house supplier testing
• MS confirmation — mass spectrometry verifying molecular identity alongside HPLC purity data
• Sequence verification — confirmation of the correct TKPRPGP sequence and molecular weight (~751.9 Da)

NexPept provides third-party COAs for every Selank batch. Researchers can view COAs here or contact us to verify any batch directly with the testing laboratory.

Storage & Handling (Research Use Only)

Proper storage and handling are essential to preserving the integrity of Selank peptide in laboratory settings. As a lyophilized heptapeptide, Selank is sensitive to moisture and light exposure — factors that can degrade the peptide backbone and reduce experimental reproducibility.

General laboratory storage considerations for Selank include:

• Store sealed lyophilized material under controlled laboratory conditions in accordance with your institution's validated SOPs
• Protect from moisture and prolonged light exposure at all times
• Keep vials sealed until required for experimental use
• Adhere to institution-approved handling and storage protocols for lyophilized synthetic heptapeptides
• Always follow your laboratory's established procedures for handling research-grade peptides

Sourcing Selank Research Peptides in Canada

When sourcing Selank peptide in Canada, researchers typically prioritize consistent quality, transparent documentation, and reliable domestic shipping. Canadian-based suppliers eliminate customs delays and temperature-chain uncertainties associated with international sourcing — important considerations for lyophilized synthetic peptides with complex amino acid sequences.

Key factors to evaluate when choosing a Selank supplier in Canada:

• Independent third-party testing with verifiable COAs
• Clear research-use-only labeling on all products
• Batch-specific documentation and lot traceability
• Transparent molecular data — CAS number, sequence, formula, purity method clearly stated
• Reliable Canadian shipping with tracking through Canada Post or FedEx

How to Compare Selank Peptide Suppliers in Canada

With growing interest in synthetic neuropeptides in Canada, the number of domestic suppliers has expanded. Not all operate to the same documentation and testing standards. The most important differentiator is independent third-party testing — a COA issued by an external laboratory that can be verified by the researcher, rather than internally produced documentation.

Second, evaluate sequence accuracy. Selank's 7-amino-acid chain (TKPRPGP) must be synthesized correctly — even a single substitution alters receptor binding dynamics and experimental outcomes. MS verification of molecular weight (~751.9 Da) alongside HPLC purity data is the most reliable way to confirm sequence integrity. Third, consider domestic shipping reliability — Canadian-based suppliers shipping via tracked domestic carriers provide 1–5 business day delivery with no customs risk. Finally, assess labeling transparency: a trustworthy supplier will clearly label Selank as a research-use-only compound with no dosing, reconstitution, or administration claims.

Related Research Peptides Available in Canada

Researchers exploring Selank peptide may also be interested in related synthetic neuropeptides and other Canadian research compounds with overlapping research contexts:

• Semax Research Peptide Overview — a synthetic ACTH(4–7) analogue studied for neurotrophic factor modulation, frequently examined alongside Selank in preclinical neurochemistry research
• Ipamorelin Research Peptide Overview — a pentapeptide growth hormone secretagogue studied in endocrine and metabolic research
• GHK-Cu Research Peptide Overview — a naturally occurring copper-binding tripeptide with an established preclinical literature base
• Buy Peptides Canada — full catalogue of lab-tested research peptides available in Canada
• Research Peptides in Canada — sourcing, regulation, and quality guidance for Canadian researchers
• What Are Research Peptides? — peptide classification and in vitro research context

Common Questions About Selank Peptide

Selank Peptide Research: Key Points

• Selank (TP-7) is a synthetic heptapeptide, CAS 129954-34-3, MW ~751.9 Da, sequence TKPRPGP
• Structurally derived from tuftsin (Thr-Lys-Pro-Arg) with a C-terminal Pro-Gly-Pro extension for metabolic stability
• Studied in vitro for GABAergic modulation, enkephalinase inhibition, serotonin metabolism, and immune signalling
• Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences
• Frequently studied alongside Semax in preclinical neurochemistry research
• Supplied as lyophilized powder — 10 mg per vial
• Verified to ≥99% purity by independent HPLC and mass spectrometry
• Batch-specific COAs available from NexPept
• Not authorized by Health Canada for human or veterinary use
• Available domestically in Canada with tracked shipping nationwide

This guide is intended to provide a complete research overview of Selank peptide for Canadian laboratory researchers. Understanding molecular profile, sourcing standards, and documentation requirements helps support more consistent and reliable in vitro research outcomes when working with synthetic neuropeptide research compounds in Canada.